Clarithromycin-Related Thrombophlebitis: A Rare yet Noteworthy Complication
Global Journal of Critical Care and Emergency Medicine · 2025
DOI: 10.33425/3065-5641.1012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Journal of Critical Care and Emergency Medicine, 2025. Verfasst von Irrum Abdullah und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Clarithromycin, a widely used macrolide antibiotic, is generally well tolerated but can rarely cause thrombophlebitis following intravenous administration. We present a case of a 24-year-old male diagnosed with pneumonia, treated with intravenous clarithromycin and piperacillin-tazobactam. While his respiratory symptoms improved, he developed sudden-onset pain, swelling, and tenderness in his left upper limb on the third day of treatment. Doppler ultrasound confirmed cephalic vein thrombophlebitis, with patent deep veins. The patient was successfully managed with subcutaneous fondaparinux and oral antibiotics, leading to full recovery. This case highlights the need for vigilance in detecting clarithromycin-induced thrombophlebitis, as early intervention can prevent complications.
Zitieren
APA
Abdullah, I., Mustafa, M. B., ajmi, L. A., & El-Ghousain, H. (2025). Clarithromycin-Related Thrombophlebitis: A Rare yet Noteworthy Complication. Global Journal of Critical Care and Emergency Medicine. https://doi.org/10.33425/3065-5641.1012
Vancouver
Abdullah I, Mustafa MB, ajmi LA, El-Ghousain H. Clarithromycin-Related Thrombophlebitis: A Rare yet Noteworthy Complication. Global Journal of Critical Care and Emergency Medicine. 2025. doi:10.33425/3065-5641.1012
BibTeX
@article{Abdullah2025,
author = {Abdullah, Irrum and Mustafa, Mian Bilal and ajmi, Lojain Al and El-Ghousain, Husam},
title = {Clarithromycin-Related Thrombophlebitis: A Rare yet Noteworthy Complication},
journal = {Global Journal of Critical Care and Emergency Medicine},
year = {2025},
doi = {10.33425/3065-5641.1012}
}
EUVIMED